The use of analytics and AI-powered methodologies enables the identification of significant patterns across several trials.

Trinity Biotech (TRIB) announced a strategic collaboration with a leading bioinformatics company to conduct advanced analysis on clinical trial ...

Exploratory Phase 2 analysis shows Verrica’s novel oncolytic peptide, VP-315, reprograms the tumor microenvironment, ...

As biotechs scale up, streamlining the planning, execution, and monitoring of outsourced clinical trials becomes critical. While CROs manage the day-to-day operations, sponsors are ultimately ...

With a cloud-based data platform, healthcare organizations can more effectively harness data in the electronic health record ...

The biopharma industry of Europe can use AI to leverage its vast stores of health data to address key challenges.

Without visibility into how clinician decisions impact quality and cost, even the highest-quality doctors are flying blind ...

Team Select Home Care has launched a predictive analytics platform that has quickly paid off with a significant reduction in ...

The biopharmaceutical sector is closely monitoring Viking Therapeutics as compelling new clinical results for its obesity ...

Altimmune’s pemvidutide shows promising Phase IIb MASH results; see key benefits, risks, and a bullish outlook. Read here for ...

Translational study shows that multiple immunological biomarkers predict the clinical activity of PDS0101 combination therapy PDS01ADC reprograms natural killer (NK) cells to possess characteristics ...